Next-gen Mpro inhibitor: Promising new drug candidate against Omicron and other SARS-CoV-2 variants
A recent Nature Signal Transduction and Targeted Therapy journal study demonstrated the potential antiviral activity of a new Mpro inhibitor (SY110) against SARS-CoV-2 Omicron and its sublineages.
Source: news-medical.net